Condition
PAP
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Enrolling By Invitation1
Recruiting1
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06767111Enrolling By Invitation
Techcyte SureView Cervical Cytology System Clinical Validation Study
NCT06930989Completed
Primary Prevention Long-term Registry Study in OSA and Hypertension. Survival Analysis 2010-2022
NCT00461188Recruiting
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA
NCT03721445Unknown
Could HRV be a Valuable Predictor for CPAP Adherence?
Showing all 4 trials